Xu Gao

机构：Yanbian University, Second Affiliated Hospital of Xi'an Jiaotong University · ORCID：0000-0003-2014-5875

发表论文 30 篇 · 总被引 906 次 · h-index 11

代表论文

• Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis (2021 · Journal of Hepatology · 被引 422)
• Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States (2022 · Journal of Hepatology · 被引 101)
• Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma (2023 · JAMA Oncology · 被引 84)
• Excess diabetes mellitus-related deaths during the COVID-19 pandemic in the United States (2022 · EClinicalMedicine · 被引 56)
• Prevalence and clinical application of TMPRSS2-ERG fusion in Asian prostate cancer patients: a large-sample study in Chinese people and a systematic review (2019 · Asian Journal of Andrology · 被引 55)
• Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy (2024 · Hepatology · 被引 37)